These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15327729)

  • 1. Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease.
    Testa JA; Ivnik RJ; Boeve B; Petersen RC; Pankratz VS; Knopman D; Tangalos E; Smith GE
    J Int Neuropsychol Soc; 2004 Jul; 10(4):504-12. PubMed ID: 15327729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.
    Heidler-Gary J; Gottesman R; Newhart M; Chang S; Ken L; Hillis AE
    Dement Geriatr Cogn Disord; 2007; 23(3):184-93. PubMed ID: 17220629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical dementia: an Italian multicentre study on amnestic mild cognitive impairment.
    Perri R; Serra L; Carlesimo GA; Caltagirone C;
    Dement Geriatr Cogn Disord; 2007; 23(5):289-300. PubMed ID: 17356272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease.
    Ferman TJ; Smith GE; Boeve BF; Graff-Radford NR; Lucas JA; Knopman DS; Petersen RC; Ivnik RJ; Wszolek Z; Uitti R; Dickson DW
    Clin Neuropsychol; 2006 Dec; 20(4):623-36. PubMed ID: 16980250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
    Sarazin M; Berr C; De Rotrou J; Fabrigoule C; Pasquier F; Legrain S; Michel B; Puel M; Volteau M; Touchon J; Verny M; Dubois B
    Neurology; 2007 Nov; 69(19):1859-67. PubMed ID: 17984454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
    Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
    Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.
    Saka E; Elibol B
    Parkinsonism Relat Disord; 2009 Nov; 15(9):688-91. PubMed ID: 19446489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonepisodic memory deficits in amnestic MCI.
    Economou A; Papageorgiou SG; Karageorgiou C; Vassilopoulos D
    Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
    Lam LC; Lui VW; Tam CW; Chiu HF
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):876-82. PubMed ID: 16116581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of sound naming in early Alzheimer's disease.
    Jeon HA; Lee KM
    J Int Neuropsychol Soc; 2009 Mar; 15(2):231-8. PubMed ID: 19203436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
    Small BJ; Gagnon E; Robinson B
    Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
    Egerházi A; Berecz R; Bartók E; Degrell I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):746-51. PubMed ID: 17289240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.